More articles about: Obesity & Weight Management

Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.

Losing weight can feel like a constant uphill battle for many people. However, patients like Marsha Burks found success with The Weight Navigation Program at Michigan Medicine, a program aiming to make weight loss easier with structured, individualized support.

How a gene for obesity affects the brain: The discovery could lead to new treatments for metabolic diseases with fewer side effects

Michigan Medicine research study aims to address inflammation’s role in diseases of the heart and brain.

A national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.

A weight navigation program for primary care patients with obesity led to more use of proven weight management strategies and more weight loss

A research team, led by Michigan Medicine and in partnership with Hurley Medical Center, finds that nearly three-quarters of patients at a clinic in Flint, Mich., a community that is predominantly Black and socioeconomically disadvantaged, had neuropathy — of which 75% was undiagnosed.

Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss.

Obesity care under a health care provider’s supervision, whether through nutrition counseling, medication, meal replacement or bariatric surgery, can help people with high BMI, but many don’t receive it.

Cardiologist shares how weight loss medications may impact cardiovascular health.

Investigators found that people with obesity who underwent bariatric surgery had stable cognition two years later. Researchers say it suggests that bariatric surgery may mitigate the natural history of cognitive decline expected in people with obesity.

Drugs approved for people with obesity or diabetes, such as Ozempic and Wegovy, can reduce risk for older adults; a new poll shows attitudes toward them

A conversation with Dr. Julie Lumeng on pediatrics, nutritional sciences and emerging science in child development and behavior.

Recent research from the University of Michigan Health suggests that bariatric surgery may reverse diabetes complications for people with obesity. Learn more about this groundbreaking study and its potential implications for diabetes treatment.

A gastroenterologist discusses several non-invasive therapies for treating obesity